Other
Salix Pharma will buy Santarus for $2.12 billion
Salix Pharmaceuticals will buy Santarus for about $2.12 billion to add to its roster of drugs.
Nov 7, 2013
0
0
Page 13 - News tagged with stocking
Other
Indian drug giant Dr Reddy's Q2 profit up 69%
India's second-largest drugmaker Dr Reddy's Laboratories on Tuesday reported a 69.4 percent jump in quarterly net profit, as profit margins rose helped by improved sales.
Oct 31, 2013
0
0
Medications
Indian drugmaker Ranbaxy faces new US regulation woes (Update 2)
Shares in Indian generic drugs giant Ranbaxy Laboratories crashed by as much as 35 percent on Monday after the US Food and Drug Administration suspended imports from one of its factories.
Sep 16, 2013
0
0
Other
Perrigo to buy Elan for $8.6B, seeks tax savings (Update)
U.S. drugmaker Perrigo agreed Monday to buy Ireland's Elan for $8.6 billion in a deal that should allow the rapidly growing company to reduce its tax bill and boost its royalty stream.
Jul 29, 2013
0
0
Other
Royalty Pharma lets Elan takeover bid expire
Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.
Jun 18, 2013
0
0
Medications
Apricus impotence drug approved in 10 countries
Apricus Biosciences Inc. said Monday that its impotence drug Vitaros has been approved in 10 European countries.
Jun 10, 2013
0
0
Other
KaloBios Pharma edges higher following IPO
(AP)—Shares of respiratory drug maker KaloBios Pharmaceuticals are inching higher on the first day of trading.
Feb 1, 2013
0
0
Other
Pfizer Q4 net jumps on sale of nutrition business
Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. The drugmaker's ...
Jan 29, 2013
0
0
Other
US wants more information from Roche on Illumina bid
Swiss pharmaceutical group Roche said Tuesday the US Federal Trade Commission had requested additional information on its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina.
Mar 13, 2012
0
0
Medications
US Pfizer, India's Biocon scrap insulin pact
India's largest biotechnology firm, Biocon, and US pharmaceutical giant Pfizer said Tuesday they would scrap a joint plan to sell insulin products, sending Biocon's shares plunging.
Mar 13, 2012
0
0
